Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Fancy who wrote (3064)	12/2/1997 12:13:00 PM
From: Biomaven	Read Replies (1) \| Respond to of 6136

Steve: Well the buyer of the 4000 Dec 40 puts that traded just after Roche made the contact certainly made an "informed" decision! I doubt it was the brokerage firm, but I'd very much like to know who it was. Enough of a coincidence, I wonder, for Nasdaq/SEC to open an investigation? Peter

To: Steve Fancy who wrote (3064)	12/2/1997 10:30:00 PM
From: Oliver & Co	Respond to of 6136

Remember my note on Nov 21st? ====================================================================== To: margie (2930 ) From: Oliver & Co Friday, Nov 21 1997 5:39PM EST Reply # of 3084 Someone bought today over 4,000 Dec $40 puts, this,IMO, is what dropped the price, because AGPH opened going up. And there are no news. I would like your oppinion. Who, outside of an institutional investor, can do such a volume?, Why?, is there inside info? Someone is betting on AGPH to drop to ~$35 by Dec. You are talking over 400,000 shares, over $16 million. What do you think? I can tell you that my broker was going bunkers. Thanks, JLL